Liposomal cytarabine and daunorubicin (CPX-351/Vyxeos)-associated distinct purpuric subtype of toxic erythema of chemotherapy: a retrospective review of 54 patients
Published: 28 January 2021| Version 1 | DOI: 10.17632/65cjrm6xkm.1
Contributors:
Joseph Stoll, , , , , , , Description
Supplemental Appendix
Files
Institutions
Memorial Sloan Kettering Cancer Center
Categories
Dermatology